← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Iveena Delivery Systems, Inc.
Salt Lake City, UT
$5,430,704
Total funding
6
Grants
Funding over time
peak $2.2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,430,704 · 6
By mechanism
R44$4,619,251 · 3
R43$811,453 · 3
Investigators at Iveena Delivery Systems, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Targeted Intraceptors for Macular Degeneration$1,002,479
R44 · FY2020 · EY
Topical Eyedrops Increasing Lysyl Oxidase and Dopamine Activity to Control Myopia$933,817
R44 · FY2025 · EY
Topical Eyedrop Therapy for Keratoconus$909,474
R44 · FY2021 · EY
Topical Eyedrop Therapy for Keratoconus$771,002
R44 · FY2020 · EY
Targeted Intraceptors for Macular Degeneration$544,245
R44 · FY2019 · EY
Targeted Intraceptors for Macular Degeneration$458,234
R44 · FY2020 · EY
Topical Eyedrops Increasing Lysyl Oxidase Activity to Control Myopia$345,000
R43 · FY2023 · EY
Topical Eyedrop Therapy for Keratoconus$224,767
R43 · FY2017 · EY
Targeted Intraceptor Nanoparticle for Macular Degeneration$216,736
R43 · FY2015 · EY
Targeted Intraceptor Nanoparticle for Macular Degeneration$24,950
R43 · FY2015 · EY